Cargando…

Molecular Profiles of HCV Cirrhotic Tissues Derived in a Panel of Markers with Clinical Utility for Hepatocellular Carcinoma Surveillance

BACKGROUND: Early hepatocellular carcinoma (HCC) detection is difficult because low accuracy of surveillance tests. Genome-wide analyses were performed using HCV-cirrhosis with HCC to identify predictive signatures. METHODOLOGY/PRINCIPAL FINDINGS: Cirrhotic liver tissue was collected from 107 HCV-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gehrau, Ricardo C., Archer, Kellie J., Mas, Valeria R., Maluf, Daniel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390353/ https://www.ncbi.nlm.nih.gov/pubmed/22792259 http://dx.doi.org/10.1371/journal.pone.0040275

Ejemplares similares

Biomarkers of disease differentiation: HCV recurrence versus acute cellular rejection
por: Gehrau, Ricardo, et al.
Publicado: (2012)

Hepatocellular carcinoma among cirrhotics - Utility of screening and surveillance programs - Review article -
por: Opriță, R, et al.
Publicado: (2014)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
por: Herrine, Steven K., et al.
Publicado: (2006)

Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010)

Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development
por: Nassar, Eman Saad, et al.
Publicado: (2021)

Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

Enterococcus gallinarum Spontaneous Bacterial Peritonitis in an HCV Cirrhotic
por: Abidali, Hussein, et al.
Publicado: (2015)

Differential metabonomic profiles of primary hepatocellular carcinoma tumors from alcoholic liver disease, HBV-infected, and HCV-infected cirrhotic patients
por: Cao, Ding, et al.
Publicado: (2017)

Hepatocellular Carcinoma in a non-Cirrhotic Liver of a HCV-Positive Woman with Sustained Viral Response
por: Nosotti, L., et al.
Publicado: (2011)

The urine microRNA profile may help monitor post-transplant renal graft function
por: Maluf, Daniel G, et al.
Publicado: (2013)

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma
por: Fu, Siyu, et al.
Publicado: (2023)

Whole Genome 5′-Methylcytosine Level Quantification in Cirrhotic HCV-Infected Egyptian Patients with and without Hepatocellular Carcinoma
por: Awad, Ahmed M., et al.
Publicado: (2020)

Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients
por: Cotte, Alexia Karen, et al.
Publicado: (2019)

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma
por: De Giorgi, Valeria, et al.
Publicado: (2009)

A non-parametric meta-analysis approach for combining independent microarray datasets: application using two microarray datasets pertaining to chronic allograft nephropathy
por: Kong, Xiangrong, et al.
Publicado: (2008)

Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b
por: Alkhatib, Mohammad, et al.
Publicado: (2021)

Occult HCV Infection (OCI) Diagnosis in Cirrhotic and Non-cirrhotic Naïve Patients by Intra-PBMC Nested Viral RNA PCR
por: Abd Alla, Mohamed Darwish Ahmed, et al.
Publicado: (2017)

Hepatocellular Carcinoma Surveillance and Treatment: A Way to Reduce Cancer-related Mortality in Cirrhotic Patients
por: Qian, Xiangjun, et al.
Publicado: (2019)

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
por: Cespiati, Annalisa, et al.
Publicado: (2023)

Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia
por: Forns, Xavier, et al.
Publicado: (2015)

Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients
por: El-Shayeb, Ayman F., et al.
Publicado: (2021)

Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
por: Liu, Yan, et al.
Publicado: (2017)

Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3
por: Ullah, Amin, et al.
Publicado: (2022)

Strong correlation by ultrasonography of hepatomegaly and the presence of co-infection in HIV/HCV cirrhotic patients
por: Vezozzo, Denise Cerqueira Paranaguá, et al.
Publicado: (2013)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
por: Goncharova, I.A., et al.
Publicado: (2023)

Hepatocellular Carcinoma Arising in Non-Cirrhotic Haemochromatosis
por: Thompson, N. P., et al.
Publicado: (1995)

Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers
por: Renzulli, Matteo, et al.
Publicado: (2022)

Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality
por: Youssef, Anas A, et al.
Publicado: (2018)

Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients
por: Smirne, Carlo, et al.
Publicado: (2022)

Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients
por: Parisse, Simona, et al.
Publicado: (2021)

Microplastics detected in cirrhotic liver tissue
por: Horvatits, Thomas, et al.
Publicado: (2022)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021)

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2021)

Phylogenetic analysis of the 5ʹ untranslated region of HCV from cirrhotic patients in Khyber Pakhtunkhwa, Pakistan
por: Ullah, Amin, et al.
Publicado: (2021)

Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients
por: Reau, Nancy, et al.
Publicado: (2023)

Assessment of serum CXCL9 and pentraxin 3 as novel markers for hepatocellular carcinoma in cirrhotic hepatitis C patients
por: Mehanna, Rafik Gabbour, et al.
Publicado: (2023)

High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma
por: Li, Hongyu, et al.
Publicado: (2022)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rsv7jilk4c6cfumoa8o14sndr